Ramaswamy campaign defends former CEO’s ‘awakening’ on China after 2018 partnership with CCP-backed firm

Ramaswamy's stance on China and plans for economic independence

Ramaswamy supports banning American companies from expanding into China.
He believes that China is the greatest external threat to America.
Ramaswamy unveiled a plan to decouple from China in a speech in Ohio.
He wants to cut ties with China and prevent them from buying land, donating to universities, and turning companies into Trojan horses.
Ramaswamy supports banning companies from doing business in China.
Ramaswamy would ban most US businesses from doing business in China unless the CCP reforms its behaviors.
He wants to implement measures to prevent data theft and intellectual property theft by China.
Ramaswamy aims to onshore critical supply chains to the US and expand trade with allies like Israel and India.
He believes that reducing dependence on China's pharmaceutical supply chain is crucial.
Ramaswamy is the only candidate to lay out a specific plan to diversify away from the Chinese-driven pharmaceutical supply chain.

Ramaswamy's company, Roivant Sciences , partnered with a Chinese Communist Party-backed company in 2018.
The partnership created a China-based firm called Sinovant Sciences.
Sinovant aimed to advance Chinese biopharmaceutical innovation globally.
Sinovant launched with a pipeline of 11 investigational biopharmaceutical products.
Ramaswamy's campaign stated that a similar launch would not be allowed under his presidency.
Ramaswamy stepped down as CEO of Roivant Sciences on February 20, 2023, to run for president .
His campaign stated that Roivant eventually wound down its operations in China due to the risks involved.
Sinovant and Cytovant, the companies formed through the partnership with China, are no longer operating but still exist for legal purposes.
Neither Sinovant nor Cytovant generated any sales or profits.
Roivant declined to comment on the matter.

Ramaswamy's campaign stated that his views on China have changed due to his experiences with Roivant Sciences .
They emphasized that the country cannot depend on an enemy for its modern way of life.
Ramaswamy's experiences have shaped his understanding of complex issues.
He is the only prominent CEO who publicly called out the risks posed by China.
Ramaswamy hopes that other candidates and private sector leaders will follow his lead.

Ramaswamy supports banning American companies from expanding into China.
Ramaswamy supports banning companies from doing business in China.
Ramaswamy would ban most US businesses from doing business in China unless the CCP reforms its behaviors.
He wants to implement measures to prevent data theft and intellectual property theft by China.

Ramaswamy stepped down as CEO of Roivant Sciences on February 20, 2023, to run for president .
His campaign stated that Roivant eventually wound down its operations in China due to the risks involved.
Sinovant and Cytovant, the companies formed through the partnership with China, are no longer operating but still exist for legal purposes.
Neither Sinovant nor Cytovant generated any sales or profits.
Roivant declined to comment on the matter.